| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Moxetumomab Pasudotox | 鲁磨西替 | 1020748-57-5 |
| Fezakinumab | FEZAKINUMAB ( 非扎奴单抗 ) | 1007106-86-6 |
| Suvizumab | SUVIZUMAB ( 舒维组单抗 ) | 914257-21-9 |
| Ponezumab | PONEZUMAB ( 泊奈组单抗 ) | 1178862-65-1 |
| Caplacizumab | 卡拉西单抗 | 915810-67-2 |
| Actoxumab | Actoxumab | 1245634-25-6 |
| Simtuzumab | 辛妥珠单抗 | 1318075-13-6 |
| Tildrakizumab | Tildrakizumab | 1326244-10-3 |
| Tovetumab | Tovetumab | 1243266-04-7 |
| Enfortumab Vedotin | 维汀-恩弗妥单抗 | 1346452-25-2 |
| Pasotuxizumab | Pasotuxizumab | 1442657-12-6 |
| Begelomab | Begelomab | 1403744-56-8 |
| Brolucizumab | Brolucizumab | 1531589-13-5 |
| Monalizumab | 莫那利珠单抗 | 1228763-95-8 |
| Refanezumab | Refanezumab | 1233953-61-1 |
| Rivabazumab | Rivabazumab | 1627519-84-9 |
| Suptavumab | Suptavumab | 1629615-23-1 |
| Lupartumab | Lupartumab | 1640971-88-5 |
| Rosmantuzumab | Rosmantuzumab | 1684393-04-1 |
| Emapalumab | 依玛鲁单抗 | 1709815-23-5 |
